Moderna plans major workforce reduction amid declining COVID-19 vaccine sales, but aims to continue investing in science and expects multiple regulatory approvals.
US and Pakistan sign oil deal, cut tariffs, as US shifts regional priorities and imposes tariffs on India over Russian energy imports.
Moderna plans major workforce reduction amid declining COVID-19 vaccine sales, but aims to continue investing in science and expects multiple regulatory approvals.
US and Pakistan sign oil deal, cut tariffs, as US shifts regional priorities and imposes tariffs on India over Russian energy imports.